Complex sleep apnea associated with use of nasal expiratory positive airway (nEPAP) device

Amit Chopra; Piyush Das; Kannan Ramar; Bruce Staats; Erik K. St Louis

doi:10.5664/jcsm.3716

Complex sleep apnea associated with use of nasal expiratory positive airway (nEPAP) device

Amit Chopra, Piyush Das, Kannan Ramar, Bruce Staats, Erik K. St Louis

Neurology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Complex sleep apnea syndrome (CompSAS) is characterized by predominant obstructive sleep disordered breathing with evolution of central disordered breathing following exposure to nasal continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea (OSA) patients. We report a case of CompSAS associated with use of a nasal expiratory positive airway (nEPAP, Provent) device. We therefore recommend obtaining objective sleep data to confirm treatment effectiveness of the nEPAP device for OSA prior to long-term prescription. Further research is warranted to understand the underlying pathophysiological mechanisms and risk factors associated with CompSAS.

Original language	English (US)
Pages (from-to)	577-579
Number of pages	3
Journal	Journal of Clinical Sleep Medicine
Volume	10
Issue number	5
DOIs	https://doi.org/10.5664/jcsm.3716
State	Published - 2014

Keywords

Complex sleep apnea syndrome
Nasal expiratory positive airway
Obstructive sleep apnea

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Neurology
Clinical Neurology

Access to Document

10.5664/jcsm.3716

Cite this

@article{7785dd6f0a304158a78bef8cc3913c96,

title = "Complex sleep apnea associated with use of nasal expiratory positive airway (nEPAP) device",

abstract = "Complex sleep apnea syndrome (CompSAS) is characterized by predominant obstructive sleep disordered breathing with evolution of central disordered breathing following exposure to nasal continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea (OSA) patients. We report a case of CompSAS associated with use of a nasal expiratory positive airway (nEPAP, Provent) device. We therefore recommend obtaining objective sleep data to confirm treatment effectiveness of the nEPAP device for OSA prior to long-term prescription. Further research is warranted to understand the underlying pathophysiological mechanisms and risk factors associated with CompSAS.",

keywords = "Complex sleep apnea syndrome, Nasal expiratory positive airway, Obstructive sleep apnea",

author = "Amit Chopra and Piyush Das and Kannan Ramar and Bruce Staats and {St Louis}, {Erik K.}",

year = "2014",

doi = "10.5664/jcsm.3716",

language = "English (US)",

volume = "10",

pages = "577--579",

journal = "Journal of Clinical Sleep Medicine",

issn = "1550-9389",

publisher = "American Academy of Sleep Medicine",

number = "5",

}

TY - JOUR

T1 - Complex sleep apnea associated with use of nasal expiratory positive airway (nEPAP) device

AU - Chopra, Amit

AU - Das, Piyush

AU - Ramar, Kannan

AU - Staats, Bruce

AU - St Louis, Erik K.

PY - 2014

Y1 - 2014

N2 - Complex sleep apnea syndrome (CompSAS) is characterized by predominant obstructive sleep disordered breathing with evolution of central disordered breathing following exposure to nasal continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea (OSA) patients. We report a case of CompSAS associated with use of a nasal expiratory positive airway (nEPAP, Provent) device. We therefore recommend obtaining objective sleep data to confirm treatment effectiveness of the nEPAP device for OSA prior to long-term prescription. Further research is warranted to understand the underlying pathophysiological mechanisms and risk factors associated with CompSAS.

AB - Complex sleep apnea syndrome (CompSAS) is characterized by predominant obstructive sleep disordered breathing with evolution of central disordered breathing following exposure to nasal continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea (OSA) patients. We report a case of CompSAS associated with use of a nasal expiratory positive airway (nEPAP, Provent) device. We therefore recommend obtaining objective sleep data to confirm treatment effectiveness of the nEPAP device for OSA prior to long-term prescription. Further research is warranted to understand the underlying pathophysiological mechanisms and risk factors associated with CompSAS.

KW - Complex sleep apnea syndrome

KW - Nasal expiratory positive airway

KW - Obstructive sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=84901231974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901231974&partnerID=8YFLogxK

U2 - 10.5664/jcsm.3716

DO - 10.5664/jcsm.3716

M3 - Article

C2 - 24812544

AN - SCOPUS:84901231974

SN - 1550-9389

VL - 10

SP - 577

EP - 579

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

IS - 5

ER -

Complex sleep apnea associated with use of nasal expiratory positive airway (nEPAP) device

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this